Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex

Abstract

Background and Purpose Salinomycin is a well‐known inhibitor of human cancer stem cells ( CSCs ). However, the molecular mechanism(s) by which salinomycin targets colorectal CSCs is poorly understood. Here, we have investigated underlying antitumour mechanisms of salinomycin in colorectal cancer cells and three tumour models. Experimental Approach The inhibitory effect of salinomycin on the Wnt/β‐catenin pathway was analysed with the SuperTopFlash reporter system. The mRNA expression of Wnt target genes was evaluated with real‐time PCR. Effects of salinomycin on β‐catenin/TCF4E interaction were examined using co‐immunoprecipitation and an in vitro GST pull‐down assay. Cell proliferation was determined by BrdU incorporation and soft agar colony formation assay. The stemness of the cells was assessed by sphere formation assay. Antitumour effects of salinomycin on colorectal cancers was evaluated with colorectal CSC xenografts, APC min/+ transgenic mice, and patient‐derived colorectal tumour xenografts. Key Results Salinomycin blocked β‐catenin/TCF4E complex formation in colorectal cancer cells and in an in vitro GST pull‐down assay, thus decreasing expression of Wnt target genes. Salinomycin also suppressed the transcriptional activity mediated by β‐catenin/LEF1 or β‐catenin/TCF4E complex and exhibited an inhibitory effect on the sphere formation, proliferation, and anchorage‐independent growth of colorectal cancer cells. In colorectal tumour xenografts and APC min/+ transgenic mice, administration of salinomycin significantly reduced tumour growth and the expression of CSC‐related Wnt target genes including LGR5. Conclusions and Implications Our study suggested that salinomycin could suppress the growth of colorectal cancer by disrupting the β‐catenin/TCF complex and thus may be a promising agent for colorectal cancer treatment.

MicroRNA-194: a novel regulator of glucagon-like peptide-1 synthesis in intestinal L cells

“…5b and c ). Since the miR-194 target genes, TCF7L2 and Foxa1 , were proved to be involved in the regulation of cell growth 27 , 28 , we speculated that miR-194 may play a role in PA-induced cytotoxicity via regulating TCF7L2 and Foxa1. Notably, the interference of miR-194 reversed the inhibitory effect of PA on cell viability (Fig.…”

The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer

“…Immunofluorescence staining was performed as previously described 38 . Briefly, cells grown on coverslips or the sectioned organoids (7 μm) were fixed with 4% paraformaldehyde and permeabilized with 0.4% Triton X-100.…”

“…Patients were diagnosed with CRC by endoscopic biopsies and subsequently confirmed by histology in the First Affiliated Hospital of Shenzhen University. Establishment of PDTXs was performed as previous described 38 , 40 . Briefly, necrotic and supporting tissues of patient's tumor were removed and about 20-30 mg of tumor fragments were subcutaneously (s.c.) implanted into the right flank of 8-week-old male NPG mice using a trocar.…”

Cancer Stem Cell for Tumor Therapy

“…It was revealed that Metformin could reduce tumorigenesis by inhibiting mitochondrial complex I [ 133 ]. Cancer therapy benefits from some antibiotics, which have been proven to inhibit the respiratory function of mitochondria; for example, salinomycin showed anti-tumor activity in colorectal cancer [ 134 ], and it was also indicated that mitochondrial function could be disrupted by salinomycin [ 135 , 136 ]. ROS are produced in the electron transport chain(ETC) during cell energy metabolism, as found in previous studies, a lower ROS level was observed to maintain CSC properties in CSC niche, thus, eliminating CSCs via a ROS inducer was proposed.…”